{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:37:54Z","timestamp":1790750274751,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.vaccine.2009.12.055","type":"journal-article","created":{"date-parts":[[2010,1,6]],"date-time":"2010-01-06T05:13:55Z","timestamp":1262754835000},"page":"2207-2213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Intranasal immunization with Leish-111f induces IFN-\u03b3 production and protects mice from Leishmania major infection"],"prefix":"10.1016","volume":"28","author":[{"given":"Shun-ichi","family":"Sakai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitsugu","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunobu","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2009.12.055_bib1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0169-4758(92)90249-2","article-title":"Estimation of population at risk of infection and number of cases of Leishmaniasis","volume":"8","author":"Ashford","year":"1992","journal-title":"Parasitol Today"},{"issue":"5","key":"10.1016\/j.vaccine.2009.12.055_bib2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0738-081X(96)00057-0","article-title":"Leishmaniasis. Public health aspects and control","volume":"14","author":"Desjeux","year":"1996","journal-title":"Clin Dermatol"},{"issue":"9185","key":"10.1016\/j.vaccine.2009.12.055_bib3","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"Herwaldt","year":"1999","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2009.12.055_bib4","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/clind\/24.4.684","article-title":"Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years","volume":"24","author":"Berman","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2009.12.055_bib5","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1086\/318121","article-title":"Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic","volume":"31","author":"Sundar","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2009.12.055_bib6","first-page":"845","article-title":"The immunology of susceptibility and resistance to Leishmania major in mice","volume":"2","author":"Sacks","year":"2002","journal-title":"Nat Rev"},{"issue":"11","key":"10.1016\/j.vaccine.2009.12.055_bib7","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1128\/iai.63.11.4261-4267.1995","article-title":"Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response","volume":"63","author":"Handman","year":"1995","journal-title":"Infect Immun"},{"issue":"5210","key":"10.1016\/j.vaccine.2009.12.055_bib8","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.7725103","article-title":"Expression cloning of a protective Leishmania antigen","volume":"268","author":"Mougneau","year":"1995","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vaccine.2009.12.055_bib9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4049\/jimmunol.139.1.221","article-title":"Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes","volume":"139","author":"Scott","year":"1987","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.12.055_bib10","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1128\/IAI.68.4.1760-1764.2000","article-title":"Comparison of the immune profile of nonhealing cutaneous Leishmaniasis patients with those with active lesions and those who have recovered from infection","volume":"68","author":"Ajdary","year":"2000","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2009.12.055_bib11","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2249.1994.tb06043.x","article-title":"Dichotomy of the human T cell response to Leishmania antigens. I. Th1-like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis","volume":"96","author":"Kemp","year":"1994","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2009.12.055_bib12","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/IAI.70.8.4215-4225.2002","article-title":"Immunization with a polyprotein vaccine consisting of the T-cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis","volume":"70","author":"Coler","year":"2002","journal-title":"Infect Immun"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2009.12.055_bib13","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1016\/S0264-410X(02)00302-X","article-title":"Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL adjuvant","volume":"20","author":"Skeiky","year":"2002","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2009.12.055_bib14","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1128\/IAI.66.7.3279-3289.1998","article-title":"Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family","volume":"66","author":"Webb","year":"1998","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2009.12.055_bib15","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.4049\/jimmunol.157.11.5034","article-title":"Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis","volume":"157","author":"Webb","year":"1996","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2009.12.055_bib16","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.4049\/jimmunol.161.11.6171","article-title":"LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile","volume":"161","author":"Skeiky","year":"1998","journal-title":"J Immunol"},{"issue":"November (45)","key":"10.1016\/j.vaccine.2009.12.055_bib17","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1016\/j.vaccine.2005.07.001","article-title":"Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals","volume":"23","author":"Gradoni","year":"2005","journal-title":"Vaccine"},{"issue":"October","key":"10.1016\/j.vaccine.2009.12.055_bib18","article-title":"Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasis","author":"Velez","year":"2009","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2009.12.055_bib19","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.4049\/jimmunol.170.11.5636","article-title":"Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen","volume":"170","author":"Boyaka","year":"2003","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2009.12.055_bib20","doi-asserted-by":"crossref","first-page":"4518","DOI":"10.4049\/jimmunol.167.8.4518","article-title":"The pulmonary environment promotes Th2 cell responses after nasal-pulmonary immunization with antigen alone, but Th1 responses are induced during instances of intense immune stimulation","volume":"167","author":"Jones","year":"2001","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2009.12.055_bib21","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.4049\/jimmunol.155.10.4621","article-title":"Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4","volume":"155","author":"Marinaro","year":"1995","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2009.12.055_bib22","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nm0795-681","article-title":"Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate","volume":"1","author":"Bukawa","year":"1995","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.vaccine.2009.12.055_bib23","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1128\/iai.64.6.2158-2166.1996","article-title":"Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection","volume":"64","author":"Debard","year":"1996","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2009.12.055_bib24","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1128\/IAI.66.8.3788-3795.1998","article-title":"Induction of protective immunity in rabbits by coadministration of inactivated Pasteurella multocida toxin and potassium thiocyanate extract","volume":"66","author":"Jarvinen","year":"1998","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2009.12.055_bib25","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1128\/iai.8.3.420-424.1973","article-title":"Immune response to vaccination with a live influenza virus (H3N2) vaccine (\u201cAnn\u201d strain)","volume":"8","author":"Pr\u00e9vost","year":"1973","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2009.12.055_bib26","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1086\/425074","article-title":"Recombinant Ascaris 16-Kilodalton protein-induced protection against Ascaris suum larval migration after intranasal vaccination in pigs","volume":"190","author":"Tsuji","year":"2004","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2009.12.055_bib27","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1128\/IAI.71.9.5314-5323.2003","article-title":"Mice intranasally immunized with a recombinant 16-kilodalton antigen from roundworm Ascaris parasites are protected against larval migration of Ascaris suum","volume":"71","author":"Tsuji","year":"2003","journal-title":"Infect Immun"},{"issue":"23","key":"10.1016\/j.vaccine.2009.12.055_bib28","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1016\/S0264-410X(03)00258-5","article-title":"Serum antibodies induced by intranasal immunization of mice with Plasmodium vivax Pvs25 co-administered with cholera toxin completely block parasite transmission to mosquitoes","volume":"21","author":"Arakawa","year":"2003","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2009.12.055_bib29","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.4049\/jimmunol.163.2.1045","article-title":"Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice","volume":"163","author":"Sun","year":"1999","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.12.055_bib30","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<424::AID-IMMU424>3.0.CO;2-U","article-title":"Selective tolerization of Th1-like cells after nasal administration of a cholera toxoid-LACK conjugate","volume":"28","author":"McSorley","year":"1998","journal-title":"Eur J Immunol"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2009.12.055_bib31","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1016\/S0264-410X(03)00427-4","article-title":"Interferon-gamma-inducing oral vaccination with Leishmania amazonensis antigens protects BALB\/c and C57BL\/6 mice against cutaneous leishmaniasis","volume":"21","author":"Pinto","year":"2003","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2009.12.055_bib32","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1128\/IAI.72.8.4521-4527.2004","article-title":"Intranasal vaccination against cutaneous leishmaniasis with a particulated leishmanial antigen or DNA encoding LACK","volume":"72","author":"Pinto","year":"2004","journal-title":"Infect Immun"},{"issue":"14","key":"10.1016\/j.vaccine.2009.12.055_bib33","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1016\/j.vaccine.2006.05.093","article-title":"Protection against cutaneous leishmaniasis by intranasal vaccination with lipophosphoglycan","volume":"25","author":"Pinheiro","year":"2007","journal-title":"Vaccine"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2009.12.055_bib34","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1002\/1521-4141(200007)30:7<2056::AID-IMMU2056>3.0.CO;2-S","article-title":"The antigen dose determines T helper subset development by regulation of CD40 ligand","volume":"30","author":"Ruedl","year":"2000","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.12.055_bib35","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1006\/cimm.1993.1037","article-title":"Modification of the immune response by oral tolerance: antigen requirements and interaction with immunogenic stimuli","volume":"146","author":"Melamed","year":"1993","journal-title":"Cell Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2009.12.055_bib36","doi-asserted-by":"crossref","first-page":"6850","DOI":"10.1128\/IAI.71.12.6850-6856.2003","article-title":"An enzymatically active a domain is required for cholera-like enterotoxins to induce a long-lived blockade on the induction of oral tolerance: new method for screening mucosal adjuvants","volume":"71","author":"Bagley","year":"2003","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2009.12.055_bib37","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.4049\/jimmunol.133.6.2892","article-title":"Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen","volume":"133","author":"Elson","year":"1984","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.12.055_bib38","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1084\/jem.167.6.1945","article-title":"Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A","volume":"167","author":"Bessen","year":"1988","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.vaccine.2009.12.055_bib39","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/jmv.10399","article-title":"Live varicella vaccine polarizes the mucosal adjuvant action of cholera toxin or its B subunit on specific Th1-type helper T cells with a single nasal coadministration in mice","volume":"70","author":"Sasaki","year":"2003","journal-title":"J Med Virol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2009.12.055_bib40","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1084\/jem.167.4.1350","article-title":"Heterogeneity of helper\/inducer T lymphocytes. II. Effects of interleukin 4- and interleukin 2-producing T cell clones on resting B lymphocytes","volume":"167","author":"Boom","year":"1988","journal-title":"J Exp Med"},{"issue":"July (6179)","key":"10.1016\/j.vaccine.2009.12.055_bib41","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/334255a0","article-title":"Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells","volume":"334","author":"Stevens","year":"1988","journal-title":"Nature"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.12.055_bib42","first-page":"425","article-title":"T(H)1 cells control themselves by producing interleukin-10","volume":"7","author":"O\u2019Garra","year":"2007","journal-title":"Nat Rev"},{"issue":"5","key":"10.1016\/j.vaccine.2009.12.055_bib43","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1128\/IAI.67.5.2643-2648.1999","article-title":"Single-dose mucosal immunization with biodegradable microparticles containing a Schistosoma mansoni antigen","volume":"67","author":"Baras","year":"1999","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2009.12.055_bib44","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nbt0598-454","article-title":"Homologous and heterologous protection after single intranasal administration of live attenuated recombinant Bordetella pertussis","volume":"16","author":"Mielcarek","year":"1998","journal-title":"Nat Biotechnol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.12.055_bib45","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1128\/iai.63.6.2100-2108.1995","article-title":"A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K\/129G, is an effective mucosal adjuvant for intranasally delivered proteins","volume":"63","author":"Roberts","year":"1995","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09019720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09019720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:16:35Z","timestamp":1759400195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09019720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0264410X09019720"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.12.055","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal immunization with Leish-111f induces IFN-\u03b3 production and protects mice from Leishmania major infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.12.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}